Data as of Aug 22
| -0.04 / -1.92%|
The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 6.00, with a high estimate of 6.50 and a low estimate of 4.00. The median estimate represents a +194.12% increase from the last price of 2.04.
The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.